Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab in Resectable Colorectal Liver Metastasis
NCT00482222Phase 3Unknown
- Sponsor
- University of Southampton
- Start
- Feb 2007
- Primary completion
- Dec 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of cetuximab in colorectal cancer (CRC), liver metastases, sponsored by University of Southampton. Status: unknown.
02
Drugs
cetuximab
03
Conditions
colorectal cancer (CRC)liver metastases
Beyond the preview
Go deeper on NCT00482222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00482222.